Infantile hemangiomas
Conditions
Interventions
experimental group: topical Tanshinone gel treatment
self-controlled group:No treatment (observation)
Sponsors
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: 1) Patients that were diagnosed as superficial infantile hemangioma according to classification and naming criteria for vascular diseases of the International Classification of Vascular Abnormalities (ISSVA); 2) The number of systemic lesion is =2; 3) The hemangioma is in a proliferative phase (the child is younger than 6 months, or more than 6 months, but less than 12 months, and the tumor still grows significantly in the near future), regardless of gender; 4) Never received other treatments; 5) Parents fully understand that this is a clinical trial and voluntarily sign the informed consent form of the legal guardian to cooperate with the referral within the prescribed time.
Exclusion criteria
Exclusion criteria: 1) Children with a history of allergies to any of the ingredients to be used; 2) There are ulcers, infections, eczema in the lesions, and it is impossible to use topical drugs; 3) Children with a history of serious congenital diseases and severe heart disease; 4) Children with clinical significant abnormality of electrocardiogram, chest X-ray, ultrasound, liver and kidney; 5) According to the researcher's judgment, the subject is not credible or poorly compliant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| wether the leision is completely removed; | — |
Secondary
| Measure | Time frame |
|---|---|
| the thickness and blood flow of the leision;Changes in appearance before and after treatment of lesions;the color of leisions; | — |
Countries
China
Contacts
Public ContactYeming Wu
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Outcome results
None listed